The DABOM Corp. has the technology to purify and analyze
disease-related circulating biomarkers (circulating tumor
cells, exosomes, cell-free nucleic acid, and etc.)in body
fluids (blood, saliva, urine, sweat, and etc.).
Exosome-based therapeutics for localized diseases / Development of exosome-based diagnostic platform
Detail View